Implant Sciences Receives Orders for the QS-B220 Bench-Top Explosives and Narcotics Trace Detectors
New Product Launch Showing Early Success in China
(firmenpresse) - WILMINGTON, MA -- (Marketwire) -- 10/12/11 -- Implant Sciences Corporation (OTCQB: IMSC) (PINKSHEETS: IMSC), a high technology supplier of systems and sensors for homeland security markets, today announced it has received its first orders for the recently introduced Quantum Sniffer™ QS-B220 bench-top explosives and narcotics trace detector from China.
With over 800 units installed in numerous locations, the Company's QS-H150 portable explosives trace detector has gained significant market traction in China for a wide range of deployments across the country. Because of its increased sensitivity for explosives and its new narcotics detection capability, the QS-B220 extends the reach of Implant Sciences' product line, providing additional opportunity for new potential customers in security, customs, and corrections facilities.
"The QS-B220 has received a very positive response from customers in China. We, and our Chinese distributors, believe the new Quantum Sniffer bench-top has the strong potential to meet and exceed the kind of sales levels we've seen in China for the QS-H150 portable unit. We anticipate that these units are just the beginning for the QS-B220," stated Glenn D. Bolduc, President and CEO of Implant Sciences.
The QS-H150 Quantum Sniffer is a hand-held explosive trace detector that uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, improvised, and homemade explosives. The QS-H150 features non-contact detection and a low-maintenance design that is self-calibrating and self-clearing, providing very high levels of operational availability.
The QS-B220 Quantum Sniffer, introduced in May 2011, is a bench-top explosives and narcotics trace detector that uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, improvised, or homemade explosives and narcotic substances. The QS-B220 continues the Implant Sciences tradition of freedom from radioactive materials, low total cost of ownership, and high operational availability.
Implant Sciences develops, manufactures and sells sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets. The Company has developed proprietary technologies used in its commercial explosive and narcotics trace detection systems which ship to a growing number of locations domestically and internationally. Implant Sciences' QS-H150 portable explosives trace detector has received Qualified Anti-Terrorism Technology Designation and the Company's QS-B220 bench-top explosives and narcotics trace detector has received a Developmental Testing & Evaluation (DT&E) Designation by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act). For further details on the Company and its products, please visit the Company's website at .
This press release may contain certain "forward-looking statements," as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause the Company's actual results to differ materially from the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risks that our explosives detection products and technologies (including any new products we may develop) may not be accepted by the Transportation Security Administration or by other U.S. government and law enforcement agencies or commercial consumers of security products; economic, political and other risks associated with international sales and operations could adversely affect our sales; our business is subject to intense competition and rapid technological change; and other risks and uncertainties described in our filings with the Securities and Exchange Commission, including our most recent Forms 10-K, 10-Q and 8-K. Such statements are based on management's current expectations and assumptions which could differ materially from the forward-looking statements.
Implant Sciences Corporation
Company Contact:
Glenn Bolduc
CEO
978-752-1700
or
Investor Contact:
Laurel Moody
646-810-0608
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 12.10.2011 - 07:00 Uhr
Sprache: Deutsch
News-ID 1045002
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
WILMINGTON, MA
Phone:
Kategorie:
Investment Services & Trading
Anmerkungen:
Diese Pressemitteilung wurde bisher 95 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Implant Sciences Receives Orders for the QS-B220 Bench-Top Explosives and Narcotics Trace Detectors
"
steht unter der journalistisch-redaktionellen Verantwortung von
Implant Sciences (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
